Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis
Circulation · 2025
DOI: 10.1161/circulationaha.124.069323 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation, 2025. Verfasst von Daniele Giacoppo und 59 weiteren Autor:innen. Beteiligte Einrichtung: Azienda Ospedaliero-Universitaria Policlinico Rodolico-San Marco, University of Catania, Italy (D.G., E.C., M.B., C.T., D.C.). Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Bicuspid Aortic Valve Disease, Bioprosthesis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Differences between balloon- and self-expandable transcatheter heart valves (BE-THVs and SE-THVs, respectively) may influence the outcomes of transcatheter aortic valve replacement for bicuspid aortic valve (BAV) stenosis. METHODS: Consecutive patients undergoing transcatheter aortic valve replacement with BE-THV or SE-THV for computed tomography–diagnosed bicuspid aortic valve stenosis at 29 centers were included. The primary outcome was death or stroke. After propensity score matching in 10 data sets generated by multiple imputation, outcomes from transcatheter aortic valve replacement to 3-year follow-up were computed by multivariable binomial logistic mixed-effects models, multivariable linear mixed-effects models, or multivariable frailty models accounting for center-related influences and residual confounding effects (doubly robust adjustment). The results were replicated by inverse probability of treatment weighting and multivariable adjustment. RESULTS: A total of 1443 consecutive patients with bicuspid aortic valve stenosis undergoing BE-THV (n=860) or SE-THV (n=583) implantation were included. In-hospital and 30-day death or stroke did not significantly differ between BE-THV and SE-THV groups (5.1% versus 6.1%; hazard ratio after propensity score matching, 1.02 [95% CI, 0.51–2.02]). BE-THV implantation was associated with higher annulus rupture and mean transvalvular gradient compared with SE-THV implantation. In contrast, SE-THV implantation was associated with higher additional valve implantation and paravalvular regurgitation compared with BE-THV implantation. The results were consistent across the statistical methods used and between early- and new-generation THVs. At 30 days, pacemaker implantation was lower in the BE-THV group compared with the SE-THV group (11.9% versus 18.6%; hazard ratio after propensity score matching, 0.58 [95% CI, 0.36–0.93]). This result did not depend on the statistical method used. At 3 years, consistent with the 1- and 2-year analyses, death or stroke was not significantly different between the BE-THV and SE-THV groups (23.7% versus 26.2%; hazard ratio after propensity score matching, 0.99 [95% CI, 0.65–1.51]). Death or stroke across major clinical, anatomical, functional, and procedural conditions was consistent with the main analysis. After inverse probability of treatment weighting and multivariable adjustment, these conclusions remained unchanged. CONCLUSIONS: In patients undergoing transcatheter aortic valve replacement for bicuspid aortic valve stenosis, death or stroke does not significantly differ between those receiving a BE-THV and those receiving an SE-THV over a follow-up of 3 years. BE-THV is associated with higher transvalvular mean gradient and more frequent annulus rupture, whereas SE-THV is associated with more frequent moderate to severe aortic regurgitation, additional THV implantation, and permanent pacemaker implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Azienda Ospedaliero-Universitaria Policlinico Rodolico-San Marco, University of Catania, Italy (D.G., E.C., M.B., C.T., D.C.).
- Cardiovascular Research Institute, Mater Private Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland (D.G., I.C., M.S.S., R.A.B.).
- Deutsches Herzzentrum München, Technisches Universität München, Germany (D.G., H.A.A.-C., E.X., J.M.M., J.Z., H.R., R.L., A.K., M.J., A.M.K., R.A.B.).
- Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Mexico City, Mexico (H.A.A.-C.).
- Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, Japan (Y.M.).
- Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Italy (Y.M., T.F., G.T.).
ORCID-Profile: Daniele Giacoppo, Hector A Alvarez-Covarrubias, Erion Xhepa, Yuji Matsuda, Stefano Cangemi, Jonathan M Michel, Anna Sannino, Enrico Criscione, Motoki Fukutomi, Manuel Hein, Romain Didier, David Meier, Taishi Okuno, Sebastian Ludwig, Marco Ancona, Dimitry Schewel, Tommaso Fabris, Flavien Vincent, Hendrik Ruge, Mattia Lunardi, Marco Barbanti, Vasilis Babaliaros, Martine Gilard, Matteo Montorfano, Paul Grayburn, Philipp Ruile, Nicolas M Van Mieghem, George Dangas, Corrado Tamburino, Niklas Schofer, Francesco Burzotta, Eric Van Belle, Franz-Josef Neumann, Ran Kornowski, Flavio Ribichini, Stephan Windecker, Giuseppe Tarantini, Thomas Pilgrim, Roxana Mehran, Davide Capodanno, Adnan Kastrati, Michael Joner
Zitieren
APA
Giacoppo, D., A Alvarez-Covarrubias, H., Xhepa, E., Matsuda, Y., Cangemi, S., Michel, J. M., Sannino, A., Ziegelmüller, J., Criscione, E., Fukutomi, M., Hein, M., Didier, R., Meier, D., Okuno, T., Ludwig, S., Ancona, M., Schewel, D., Fabris, T., Vincent, F., …, & Spence, M. S. (2025). Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis. Circulation. https://doi.org/10.1161/circulationaha.124.069323
Vancouver
Giacoppo D, A Alvarez-Covarrubias H, Xhepa E, Matsuda Y, Cangemi S, Michel JM, et al. Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis. Circulation. 2025. doi:10.1161/circulationaha.124.069323
BibTeX
@article{Giacoppo2025,
author = {Giacoppo, Daniele and A Alvarez-Covarrubias, Hector and Xhepa, Erion and Matsuda, Yuji and Cangemi, Stefano and Michel, Jonathan M and Sannino, Anna and Ziegelmüller, Johannes and Criscione, Enrico and Fukutomi, Motoki and Hein, Manuel and Didier, Romain and Meier, David and Okuno, Taishi and Ludwig, Sebastian and Ancona, Marco and Schewel, Dimitry and Fabris, Tommaso and Vincent, Flavien and Voigtländer, Lisa and Ziviello, Francesca and Tanner, Richard and Tamburino, Claudia and Ruge, Hendrik and Lunardi, Mattia and Codner, Pablo and Barbanti, Marco and Nietlispach, Fabian and Nef, Holger and Casserly, Ivan and Babaliaros, Vasilis and Tchetche, Didier and Lange, Rüdiger and Gilard, Martine and Montorfano, Matteo and Landt, Martin and Grayburn, Paul and Ruile, Philipp and Van Mieghem, Nicolas M and Bedogni, Francesco and Dangas, George and Tamburino, Corrado and Schofer, Niklas and Burzotta, Francesco and Van Belle, Eric and Neumann, Franz-Josef and Kornowski, Ran and Ribichini, Flavio and Mylotte, Darren and Windecker, Stephan and Richardt, Gert and Sondergaard, Lars and Webb, John G and Tarantini, Giuseppe and Pilgrim, Thomas and Mehran, Roxana and Capodanno, Davide and Kastrati, Adnan and Joner, Michael and Spence, Mark S},
title = {Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis},
journal = {Circulation},
year = {2025},
doi = {10.1161/circulationaha.124.069323}
}
EUVIMED